In the Media

Boston Globe reporter Jonathan Saltzman writes that a Covid-19 diagnostic test developed by MIT researchers has received FDA approval. Saltzman explains that the test works by “programming a molecule to detect the presence of a specific genetic signature ― in this case, the signature for the coronavirus. When the signature is found, an enzyme is activated and releases a detectable signal.”